Compare WDS & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WDS | IDXX |
|---|---|---|
| Founded | 1954 | 1983 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.6B | 45.4B |
| IPO Year | 2002 | 1996 |
| Metric | WDS | IDXX |
|---|---|---|
| Price | $24.16 | $546.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $721.67 |
| AVG Volume (30 Days) | 586.6K | ★ 596.3K |
| Earning Date | 02-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.50% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 7.74 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $10.14 | $10.88 |
| Revenue Next Year | $4.92 | $8.59 |
| P/E Ratio | ★ $11.81 | $72.64 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $14.27 | $518.55 |
| 52 Week High | $25.19 | $769.98 |
| Indicator | WDS | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 65.79 | 42.24 |
| Support Level | $22.11 | $536.07 |
| Resistance Level | $24.91 | $583.93 |
| Average True Range (ATR) | 0.34 | 19.95 |
| MACD | 0.07 | -3.82 |
| Stochastic Oscillator | 91.97 | 7.55 |
Incorporated in 1954 and named after the small Victorian town of Woodside, Woodside's early exploration focus moved from Victoria's Gippsland Basin to Western Australia's Carnarvon Basin. First LNG production from the North West Shelf came in 1984. BHP Billiton and Shell each had 40% shareholdings before BHP sold out in 1994 and Shell sold down to 34%. In 2017 Shell sold its entire shareholding. Woodside is one of the most LNG-leveraged companies globally.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.